RSPH vs. SPY
RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and SPY (State Street SPDR S&P 500 ETF) are both exchange-traded funds - RSPH is a Health & Biotech Equities fund tracking the S&P 500 Equal Weighted / Health Care -SEC, while SPY is a S&P 500 fund tracking the S&P 500 Index. Both are passively managed. Over the past 10 years, RSPH returned 7.86%/yr vs 15.49%/yr for SPY. A 0.74 correlation means they provide meaningful diversification when combined. RSPH charges 0.40%/yr vs 0.09%/yr for SPY.
Performance
RSPH vs. SPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RSPH achieves a -3.49% return, which is significantly lower than SPY's 10.91% return. Over the past 10 years, RSPH has underperformed SPY with an annualized return of 7.86%, while SPY has yielded a comparatively higher 15.49% annualized return.
RSPH
- 1D
- -1.16%
- 1M
- 1.35%
- YTD
- -3.49%
- 6M
- -3.00%
- 1Y
- 8.54%
- 3Y*
- 2.93%
- 5Y*
- 2.46%
- 10Y*
- 7.86%
SPY
- 1D
- -0.70%
- 1M
- 5.05%
- YTD
- 10.91%
- 6M
- 10.91%
- 1Y
- 27.98%
- 3Y*
- 22.35%
- 5Y*
- 13.83%
- 10Y*
- 15.49%
RSPH vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RSPH Invesco S&P 500 Equal Weight Health Care ETF | -3.49% | 9.52% | -0.94% | 3.95% | -9.40% | 23.19% | 18.83% | 25.48% | -0.66% | 23.70% |
SPY State Street SPDR S&P 500 ETF | 10.91% | 17.72% | 24.89% | 26.18% | -18.18% | 28.73% | 18.33% | 31.22% | -4.57% | 21.71% |
Correlation
The correlation between RSPH and SPY is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.47 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.55 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.67 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.72 |
Correlation (All Time) Calculated using the full available price history since Nov 8, 2006 | 0.74 |
Over the past year, the correlation between RSPH and SPY has dropped to 0.47 - well below their long-term average of 0.74, suggesting their price drivers have been diverging.
RSPH vs. SPY - Sectors Allocation Comparison
Sectors
RSPH
SPY
Healthcare
Financial Services
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
RSPH
SPY
Financial Services
RSPH
SPY
Basic Materials
RSPH
-
SPY
Communication Services
RSPH
-
SPY
Consumer Cyclical
RSPH
-
SPY
Consumer Defensive
RSPH
-
SPY
Energy
RSPH
-
SPY
Industrials
RSPH
-
SPY
Real Estate
RSPH
-
SPY
Technology
RSPH
-
SPY
Utilities
RSPH
-
SPY
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RSPH vs. SPY — Risk / Return Rank
RSPH
SPY
RSPH vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P 500 Equal Weight Health Care ETF (RSPH) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RSPH | SPY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.56 | 2.38 | -1.82 |
Sortino ratioReturn per unit of downside risk | 0.90 | 3.24 | -2.34 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.43 | -0.32 |
Calmar ratioReturn relative to maximum drawdown | 0.76 | 3.16 | -2.41 |
Martin ratioReturn relative to average drawdown | 1.91 | 14.72 | -12.81 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RSPH | SPY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.56 | 2.38 | -1.82 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.15 | 0.82 | -0.66 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | 0.87 | -0.42 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.58 | 0.59 | -0.01 |
Drawdowns
RSPH vs. SPY - Drawdown Comparison
The maximum RSPH drawdown since its inception was -40.49%, smaller than the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for RSPH and SPY.
Loading charts...
Drawdown Indicators
| RSPH | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.49% | -55.19% | +14.70% |
Max Drawdown (1Y)Largest decline over 1 year | -10.87% | -8.88% | -1.99% |
Max Drawdown (3Y)Largest decline over 3 years | -17.13% | -18.76% | +1.63% |
Max Drawdown (5Y)Largest decline over 5 years | -21.95% | -24.50% | +2.55% |
Max Drawdown (10Y)Largest decline over 10 years | -30.44% | -33.72% | +3.28% |
Current DrawdownCurrent decline from peak | -7.58% | -0.70% | -6.88% |
Average DrawdownAverage peak-to-trough decline | -6.14% | -9.05% | +2.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.31% | 1.91% | +2.40% |
Volatility
RSPH vs. SPY - Volatility Comparison
Invesco S&P 500 Equal Weight Health Care ETF (RSPH) has a higher volatility of 3.82% compared to State Street SPDR S&P 500 ETF (SPY) at 2.84%. This indicates that RSPH's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RSPH | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.82% | 2.84% | +0.98% |
Volatility (6M)Calculated over the trailing 6-month period | 10.44% | 8.90% | +1.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.45% | 11.83% | +3.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.26% | 17.05% | -0.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.72% | 17.94% | -0.22% |
RSPH vs. SPY - Expense Ratio Comparison
RSPH has a 0.40% expense ratio, which is higher than SPY's 0.09% expense ratio.
Dividends
RSPH vs. SPY - Dividend Comparison
RSPH's dividend yield for the trailing twelve months is around 0.73%, less than SPY's 0.98% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RSPH Invesco S&P 500 Equal Weight Health Care ETF | 0.73% | 0.70% | 0.71% | 0.66% | 0.64% | 0.50% | 0.51% | 0.54% | 0.53% | 0.47% | 0.48% | 0.49% |
SPY State Street SPDR S&P 500 ETF | 0.98% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Frequently Asked Questions
RSPH and SPY have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RSPH has higher volatility (3.82%) compared to SPY (2.84%). In terms of maximum drawdown, RSPH dropped -40.49% vs SPY's -55.19%.
On 10-year performance, SPY leads with 15.49% vs 7.86% for RSPH. On fees, SPY is cheaper at 0.09% per year. On volatility, SPY has been the lower-risk option at 2.84%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SPY has performed better with a 15.49% return vs 7.86%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SPY is cheaper with a 0.09% expense ratio, compared with 0.40% for RSPH.
SPY has the higher dividend yield at 0.98%, compared with 0.73% for RSPH.
RSPH is categorized as Health & Biotech Equities, while SPY is S&P 500. RSPH tracks S&P 500 Equal Weighted / Health Care -SEC, while SPY tracks S&P 500 Index. They also come from different issuers: Invesco and State Street. Their fees differ too: 0.40% for RSPH and 0.09% for SPY.
SPY currently has the higher Sharpe Ratio (2.38 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RSPH and SPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer